The Validity of Optical Coherence Tomography Angiography as a Screening Test for the Early Detection of Retinal Changes in Patients with Hydroxychloroquine Therapy.
Adult
Aged
Antirheumatic Agents
/ toxicity
Cross-Sectional Studies
Female
Fluorescein Angiography
Fovea Centralis
/ blood supply
Humans
Hydroxychloroquine
/ toxicity
Male
Middle Aged
Prospective Studies
Retinal Diseases
/ chemically induced
Retinal Vessels
/ drug effects
Rheumatic Diseases
/ drug therapy
Tomography, Optical Coherence
Visual Acuity
Chloroquine
foveal avascular zone
hydroxychloroquine
optical coherence tomography angiography
vessel density
Journal
Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
8
11
2018
medline:
2
5
2020
entrez:
8
11
2018
Statut:
ppublish
Résumé
The aim of this study was to quantitatively compare both the vessel density of macular capillary plexuses and the foveal avascular zone (FAZ) areas of patients receiving hydroxychloroquine (HCQ) therapy for more than 5 years while using age- and sex-matched controls. The patients undergoing HCQ who were screened for toxic effects were evaluated. The FAZ parameters included the area, perimeter, and the acircularity index. The foveal density and vessel density values of both the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were measured using optical coherence tomography angiography (OCTA). This study included 80 eyes of 40 subjects: 20 subjects in the HCQ group and 20 subjects in the control group. The FAZ perimeter and the FAZ area in the SCP and full retinal vasculature were significantly larger in the HCQ group than in the control group (p < 0.05 for all). Additionally, the vessel density of fovea in the SCP and DCP was significantly lower in the HCQ group than in the control group (p < 0.05 for all). OCTA provides objective documentation about FAZ and vessel density features in patients using long-term HCQ therapy before toxicity begins, and it can be used as a screening tool for detecting early changes in the macula.
Identifiants
pubmed: 30403878
doi: 10.1080/02713683.2018.1545912
doi:
Substances chimiques
Antirheumatic Agents
0
Hydroxychloroquine
4QWG6N8QKH
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM